[
  {
    "id": 91,
    "question": "Large acute MCA stroke and history of Afib what to give for acute management",
    "option_a": "Aspirin",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAcute management of ischemic stroke centers on rapid restoration of cerebral blood flow to save ischemic brain tissue. In patients with a large middle cerebral artery (MCA) stroke, timely administration of reperfusion therapies is essential, particularly if the etiology is cardioembolic, as in atrial fibrillation (Afib).\n\n**Pathophysiology**\n\nIn a cardioembolic stroke, a clot originating from the heart occludes a cerebral vessel. For large vessel occlusions, the resulting ischemia can progress rapidly to infarction. The most beneficial acute interventions aim to lyse or physically remove the clot to restore perfusion. The primary risk with delayed or inappropriate therapy (e.g., giving only antiplatelet agents) is continued infarction and a higher risk of hemorrhagic transformation.\n\n**Clinical Correlation**\n\nPatients with large MCA strokes typically present with significant neurological deficits such as hemiplegia, aphasia (if the dominant hemisphere is affected), and visual field deficits. The presence of Afib strongly suggests a cardioembolic cause, which reinforces the need for rapid reperfusion therapy rather than solely antiplatelet therapy.\n\n**Diagnostic Approach**\n\nInitial evaluation with non-contrast CT is performed to rule out hemorrhage, followed by CT angiography (CTA) to assess vessel occlusion. Differential diagnoses include lacunar infarcts or hemorrhagic stroke, but clinical context and imaging findings in large MCA territory point to a cardioembolic large vessel occlusion.\n\n**Management Principles**\n\nFor eligible patients within 4.5 hours of stroke onset, first-line management is intravenous thrombolysis with tissue plasminogen activator (tPA), provided there are no contraindications. For large vessel occlusions, mechanical thrombectomy is often the next step. Aspirin is typically used later for antiplatelet therapy once reperfusion strategies are complete and after a waiting period (usually 24 hours post-thrombolysis) to minimize hemorrhagic risk. In pregnant or lactating patients, thrombolytic therapy may be considered if the benefits outweigh the risks, with careful monitoring and consultation with maternal\u2010fetal medicine specialists.\n\n**Option Analysis**\n\nOption A (Aspirin) is incorrect in the hyperacute management of a large MCA stroke, especially when the patient is within the window for reperfusion therapies. The correct acute intervention is intravenous thrombolysis (typically represented in alternative answer options as IV tPA), with thrombectomy considered if large vessel occlusion is confirmed. Since the marked answer was Aspirin, it does not align with the standard of care for eligible patients.\n\n**Clinical Pearls**\n\n1. 'Time is brain'\u2014rapid administration of reperfusion therapy is critical in large vessel occlusions. 2. In cardioembolic strokes from Afib, reperfusion (via IV tPA and/or mechanical thrombectomy) is the priority over antiplatelet therapy in the acute phase. 3. Aspirin is generally deferred until at least 24 hours after thrombolytic therapy to reduce hemorrhagic risk.\n\n**Current Evidence**\n\nRecent guidelines from the American Heart Association and European Stroke Organisation strongly support the use of IV thrombolysis within 4.5 hours of symptom onset and mechanical thrombectomy for eligible patients with large vessel occlusion. Emerging evidence also addresses careful patient selection to minimize hemorrhagic transformation, even in large infarcts.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 92,
    "question": "Brain MRI is showing unilateral watershed infarction what to order?",
    "option_a": "CTA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nWatershed infarctions occur in regions of the brain that lie at the junctions of major vascular territories. These infarcts are typically a result of hypoperfusion and can be indicative of significant carotid artery disease when they occur unilaterally.\n\n**Pathophysiology**\n\nWatershed zones have a dual supply from adjacent arterial territories and are thus vulnerable to systemic hypotension or hemodynamic compromise. Unilateral watershed infarcts raise suspicion for ipsilateral carotid artery stenosis or occlusion, which diminishes perfusion pressure, especially during episodes of low systemic blood pressure.\n\n**Clinical Correlation**\n\nThe clinical presentation in patients with watershed infarcts often includes transient or fluctuating neurological deficits that may correspond to fluctuating cerebral perfusion. Unilateral findings particularly prompt evaluation of the carotid artery ipsilateral to the infarct.\n\n**Diagnostic Approach**\n\nAfter initial MRI findings of a unilateral watershed infarct, vascular imaging is the next step to evaluate for carotid pathology. Options include CT angiography (CTA), MR angiography (MRA), or carotid duplex ultrasonography. The differentiation from embolic strokes lies in the distribution and border-zone pattern seen on imaging.\n\n**Management Principles**\n\nThe evaluation of a unilateral watershed infarction includes vascular imaging to assess for carotid stenosis. Management depends on the severity of carotid disease: medically managed with antiplatelet agents and statins for moderate stenosis, or consideration of revascularization procedures (endarterectomy or stenting) for high-grade stenosis. In pregnant or lactating patients, non-invasive imaging such as duplex ultrasound or MRI/MRA is preferred to avoid ionizing radiation, and if CTA is necessary, proper shielding and dose optimization are required.\n\n**Option Analysis**\n\nOption A (CTA) is the correct next step because it provides detailed vascular imaging to evaluate carotid artery stenosis or occlusion. Alternative imaging modalities exist, but CTA is widely available and highly sensitive for detecting vascular pathology in the extracranial carotid circulation.\n\n**Clinical Pearls**\n\n1. Unilateral watershed infarcts should trigger evaluation for ipsilateral carotid stenosis. 2. CTA is a rapid and effective tool for assessing carotid and intracranial arteries. 3. Hemodynamic compromise as a cause of stroke may necessitate different management strategies compared to embolic strokes.\n\n**Current Evidence**\n\nRecent stroke guidelines endorse vascular imaging, such as CTA, as a critical component in the workup of watershed infarctions. Current research focuses on refining imaging protocols to better delineate the hemodynamic significance of carotid lesions and to guide revascularization decisions.",
    "exam_year": "2020",
    "exam_type": "Part I",
    "image_url": "page_21.png"
  },
  {
    "id": 93,
    "question": "Hemorrhagic stroke and INR of 3.1",
    "option_a": "PCC",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn patients with hemorrhagic stroke on warfarin, the elevated INR reflects anticoagulation that increases bleeding risk. Rapid reversal of coagulopathy is essential to limit hematoma expansion.\n\n**Pathophysiology**\n\nWarfarin inhibits vitamin K\u2013dependent clotting factors (II, VII, IX, and X). In the setting of intracranial hemorrhage, an INR above the therapeutic range (here 3.1) can worsen bleeding. Prothrombin complex concentrate (PCC) contains these clotting factors, allowing rapid reversal of warfarin's effects.\n\n**Clinical Correlation**\n\nPatients on warfarin who present with a hemorrhagic stroke have a higher risk of hematoma expansion. Reversal of anticoagulation is critical to minimize further bleeding and improve outcomes.\n\n**Diagnostic Approach**\n\nDiagnosis is based on clinical presentation and neuroimaging (typically CT scan) showing hemorrhage. Laboratory tests (including INR) confirm the degree of anticoagulation. Differential diagnoses include other forms of intracerebral hemorrhage such as hypertensive bleeds, aneurysmal subarachnoid hemorrhage, or vascular malformations.\n\n**Management Principles**\n\nThe first-line management includes rapid reversal of anticoagulation using PCC along with intravenous vitamin K administration. This is supported by guidelines like those from the American Heart Association/American Stroke Association. In pregnancy and lactation, reversal agents would be used similarly since the maternal benefit of stopping hemorrhage outweighs potential concerns; however, consultation with specialists is advised if anticoagulation has been used during pregnancy.\n\n**Option Analysis**\n\nOption A (PCC) is correct because it provides the clotting factors necessary for rapid reversal. Other options (though not listed) such as fresh frozen plasma (FFP) are alternatives but are generally slower and carry volume overload risks.\n\n**Clinical Pearls**\n\n\u2022 Rapid reversal of warfarin is critical in hemorrhagic strokes. \u2022 PCC achieves faster correction compared to FFP. \u2022 Always co-administer vitamin K to sustain factor synthesis.\n\n**Current Evidence**\n\nRecent guidelines and studies favor the use of four-factor PCC over FFP due to its quicker effect and lower risk profile. Updated stroke management protocols emphasize rapid correction of anticoagulation in warfarin-associated hemorrhagic stroke.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 94,
    "question": "Scenario of 82-year-old lady with ischemic stroke presented within 1 hour with no contraindications",
    "option_a": "Tpa",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAcute ischemic stroke is caused by an occlusion of a cerebral artery leading to brain ischemia. Timely administration of thrombolytics, like tissue plasminogen activator (tPA), can dissolve the clot and restore perfusion if given within the therapeutic window.\n\n**Pathophysiology**\n\nThe infarction occurs when an embolus or thrombus occludes an artery. tPA acts by catalyzing the conversion of plasminogen to plasmin, which helps break down fibrin clots and restore blood flow.\n\n**Clinical Correlation**\n\nIn an 82-year-old woman presenting within 1 hour of symptom onset and with no contraindications, immediate treatment with tPA can salvage the penumbral tissue and improve functional outcomes. Although advanced age was once considered a relative contraindication, current evidence supports its use in selected elderly patients.\n\n**Diagnostic Approach**\n\nDiagnosis is confirmed by the clinical presentation and brain imaging (noncontrast CT scan) which excludes hemorrhage. Differential diagnoses include stroke mimics (such as seizures, migraines, or hypoglycemia), but the classical rapid onset of focal deficits supports ischemic stroke.\n\n**Management Principles**\n\nFirst-line management for acute ischemic stroke within the time window (typically up to 4.5 hours from onset) is IV tPA. Blood pressure management is conservative unless levels are exceedingly high. In the elderly and during pregnancy/lactation (if applicable), tPA remains the treatment of choice if no contraindications are present; careful risk\u2013benefit analysis is essential.\n\n**Option Analysis**\n\nOption A (tPA) is correct. The absence of contraindications (e.g., recent surgery, hemorrhage) and the fact that the patient presents within the window support the use of thrombolytic therapy. Other options (not provided) would not be indicated in this early phase of ischemic stroke.\n\n**Clinical Pearls**\n\n\u2022 Time is brain; early thrombolysis significantly improves outcomes. \u2022 Advanced age is not an absolute contraindication for tPA. \u2022 Always rule out hemorrhage before administering tPA.\n\n**Current Evidence**\n\nRecent updates in stroke guidelines reaffirm the expanded window for tPA in select patients with confirmed ischemic stroke. Advanced imaging techniques help select candidates who can still benefit from thrombolysis despite older age.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 95,
    "question": "Case scenario of a lady in postpartum period presented with headache and seizure, normal brian CT what to do next? (No Mg in the choices)",
    "option_a": "CTV",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn the postpartum period, headache and seizures raise concern for several etiologies including eclampsia and cerebral venous thrombosis (CVT). When a noncontrast CT brain is normal, further vascular imaging is indicated to evaluate conditions that may not be visible on standard CT.\n\n**Pathophysiology**\n\nCVT occurs due to thrombosis of the cerebral venous sinuses, leading to impaired venous drainage, increased intracranial pressure, and potentially seizures and headache. Postpartum status is a prothrombotic state increasing the risk for CVT. In eclampsia, endothelial dysfunction and vasogenic edema (PRES) are common.\n\n**Clinical Correlation**\n\nA postpartum woman with headache and seizure with a normal CT scan suggests that the pathology might be in the venous system (CVT) or related to subtle changes not visible on a standard CT (such as PRES). Although eclampsia is common, the absence of magnesium sulfate among options forces consideration of alternative diagnoses.\n\n**Diagnostic Approach**\n\nAfter a normal CT, the next step is to use vascular imaging. MRI with MR venography is the gold standard for CVT, but if unavailable, CT venography (CTV) is an acceptable and rapid alternative. Differential diagnoses include eclamptic seizures, PRES, and other causes of postpartum seizures.\n\n**Management Principles**\n\nThe definitive management of CVT is anticoagulation (usually with low molecular weight heparin as first-line therapy), even in the presence of hemorrhage. In postpartum patients, treatment protocols remain similar; anticoagulation is considered safe in lactating women. For eclampsia (if suspected), magnesium sulfate is the treatment of choice, but since it is not an option here, the imaging workup to confirm an alternative diagnosis (i.e., CVT) is warranted.\n\n**Option Analysis**\n\nOption A (CTV) is correct in this scenario because a normal CT does not exclude CVT. Vascular imaging, such as CT venography, is necessary to identify sinus thrombosis. Other options (though not provided) might have included magnesium sulfate for eclampsia, but the question specifies that magnesium is not among the choices, making CTV the next logical step.\n\n**Clinical Pearls**\n\n\u2022 In the postpartum period, always consider CVT in women presenting with headache and seizures. \u2022 CT venography is a rapid, accessible alternative to MR venography in suspected CVT. \u2022 A normal CT does not rule out CVT or subtle changes seen in PRES.\n\n**Current Evidence**\n\nRecent studies emphasize the importance of early detection of CVT using advanced imaging techniques. Updated guidelines suggest that in patients with high clinical suspicion and a normal noncontrast CT, vascular imaging should be pursued promptly to guide management.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 96,
    "question": "Case scenario about acute ischemic stroke happened in the morning and her presented in the evening with high BP of 190/90 and asked what to do in regards to his blood pressure",
    "option_a": "No management",
    "option_b": "oral amlodipine",
    "option_c": "IV labetalol",
    "option_d": "IV nicardipine",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn acute ischemic stroke, blood pressure is often elevated as part of the body\u2019s response to maintain cerebral perfusion in the ischemic penumbra. Unless blood pressure exceeds a critical threshold, aggressive lowering may be harmful.\n\n**Pathophysiology**\n\nCerebral autoregulation in the setting of an ischemic stroke often shifts, causing the brain to be dependent on higher blood pressure to perfuse the penumbral regions. Lowering the blood pressure too aggressively can worsen ischemia in these vulnerable areas.\n\n**Clinical Correlation**\n\nA patient who presents later in the day after an acute ischemic stroke with a blood pressure of 190/90 mmHg falls below the thresholds typically necessitating urgent blood pressure lowering (usually >220/120 mmHg in those not receiving thrombolytic therapy).\n\n**Diagnostic Approach**\n\nThis management decision is based on serial blood pressure measurements, clinical assessment, and imaging confirming ischemic stroke without hemorrhagic transformation. Differential diagnoses include hypertensive emergency unrelated to stroke, but here the elevated BP is likely a physiological response.\n\n**Management Principles**\n\nFor ischemic stroke not treated with thrombolysis, current guidelines recommend permissive hypertension (up to 220/120 mmHg) to maintain perfusion to the ischemic penumbra. Therefore, no acute blood pressure management is indicated unless levels exceed these limits. In patients who are pregnant or lactating, similar principles apply; blood pressure management is generally deferred unless severely elevated, with close monitoring to avoid compromising cerebral blood flow.\n\n**Option Analysis**\n\nOption A (No management) is correct because the patient\u2019s blood pressure of 190/90 mmHg is below the threshold that would require acute intervention in an ischemic stroke patient outside the thrombolytic window. Options B, C, and D involve pharmacologic lowering, which could potentially reduce cerebral perfusion in the affected area and worsen neurological outcomes.\n\n**Clinical Pearls**\n\n\u2022 Permissive hypertension is typical in acute ischemic stroke management to optimize cerebral perfusion. \u2022 Blood pressure should only be lowered if it exceeds 220/120 mmHg in patients not receiving thrombolytic therapy. \u2022 Overzealous BP reduction can expand the ischemic core.\n\n**Current Evidence**\n\nRecent guidelines from the AHA/ASA continue to support a conservative approach to blood pressure management in acute ischemic stroke, emphasizing maintaining cerebral perfusion. Emerging research continues to explore the optimal thresholds and timing for antihypertensive therapy in various stroke subgroups.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 97,
    "question": "Intracranial bleed and asked about the blood pressure management",
    "option_a": "140/90",
    "option_b": "160/90",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn intracerebral hemorrhage (ICH), blood pressure management is critical because elevated blood pressure is associated with hematoma expansion and worsened outcomes. The goal is to reduce secondary brain injury by stabilizing the patient\u2019s blood pressure.\n\n**Pathophysiology**\n\nElevated blood pressure in the setting of an intracranial bleed can increase the hydrostatic pressure across the ruptured vessel wall, leading to hematoma enlargement. This expansion increases intracranial pressure (ICP) and may cause further brain tissue damage. Key trials such as INTERACT2 have demonstrated that careful blood pressure reduction can mitigate these effects.\n\n**Clinical Correlation**\n\nPatients with ICH typically present with sudden neurological deficits, headache, nausea, and altered consciousness. The hypertensive state may exacerbate the mass effect from the hemorrhage, leading to additional neurological deterioration as seen with signs of raised ICP.\n\n**Diagnostic Approach**\n\nDiagnosis is primarily made through non-contrast CT scanning, which distinguishes hemorrhagic stroke from ischemic stroke. Differential diagnoses include ischemic stroke, hypertensive encephalopathy, and other causes of acute neurological decline. Blood pressure monitoring is integrated into the management plan once ICH is identified.\n\n**Management Principles**\n\nFirst-line management involves stabilization with supportive care and rapid blood pressure control. Current AHA/ASA guidelines recommend that for patients presenting with ICH and systolic blood pressure between 150-220 mm Hg, lowering the systolic blood pressure to around 140 mm Hg is reasonable. IV antihypertensives (such as nicardipine or labetalol) are commonly used. In pregnancy, antihypertensive options like labetalol or hydralazine are preferred given their safety profiles, while in lactation, similar agents with minimal secretion into breast milk are chosen.\n\n**Option Analysis**\n\nOption A (140/90) is consistent with guideline recommendations targeting a systolic blood pressure of approximately 140 mm Hg to attenuate further bleeding. Option B (160/90) is less optimal because maintaining a higher blood pressure could risk further hemorrhage expansion.\n\n**Clinical Pearls**\n\n1. Rapid blood pressure control in ICH can limit hematoma expansion and improve outcomes. 2. CT imaging is the cornerstone of diagnosis in differentiating ICH from other stroke types.\n\n**Current Evidence**\n\nRecent studies including the INTERACT2 trial have reinforced the safety and potential benefit of aggressive blood pressure lowering to a target of 140 mm Hg systolic in patients with ICH. Current guidelines reflect these findings, emphasizing individualized care while balancing the risk of cerebral hypoperfusion.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 98,
    "question": "Lady with two days history of malignant left MCA and midline shift (CT was attached) transferred from another hospital what will you do for her",
    "option_a": "Craniectomy",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nMalignant middle cerebral artery (MCA) infarction refers to a large, space\u2010occupying ischemic stroke resulting in extensive cerebral edema, increased intracranial pressure (ICP), and potential herniation. Decompressive craniectomy is a surgical intervention used to relieve this pressure.\n\n**Pathophysiology**\n\nIn malignant MCA infarction, the abrupt loss of blood flow leads to neuronal death and cytotoxic edema. The ensuing swelling increases ICP and can result in midline shift, compressing vital brainstem structures. Surgical decompression helps prevent or reduce secondary injury from the mass effect.\n\n**Clinical Correlation**\n\nPatients typically present with rapid neurological deterioration including decreased consciousness, hemiparesis, and signs of raised ICP. CT imaging revealing significant edema and midline shift confirms the severity of the infarction.\n\n**Diagnostic Approach**\n\nDiagnosis is based on clinical examination supported by CT or MRI. Differential diagnoses include hemorrhagic transformation of an infarct or large territorial infarcts from other cerebrovascular territories. The presence of significant midline shift is a key indicator for surgical decompression.\n\n**Management Principles**\n\nEarly decompressive craniectomy (within 48 hours of symptom onset) has been shown to improve survival and functional outcomes. First-line management in malignant MCA infarction is surgical decompression combined with optimal medical management, including ICP control. For pregnant patients, careful coordination with obstetric teams is necessary; while decompressive craniectomy is generally safe, anesthetic and surgical planning must take fetal safety into account. In lactation, standard surgical management applies with supportive measures for the mother.\n\n**Option Analysis**\n\nOption A (Craniectomy) is correct because decompressive craniectomy is the recommended intervention for malignant MCA infarction with midline shift. Other medical management options alone (such as osmotherapy) are often insufficient in the context of malignant edema.\n\n**Clinical Pearls**\n\n1. Time is brain\u2014early decompressive surgery can significantly reduce mortality in malignant MCA syndrome. 2. CT evidence of midline shift is a critical sign indicating the need for surgical intervention.\n\n**Current Evidence**\n\nLandmark trials such as DECIMAL, DESTINY, and HAMLET have provided strong evidence that early decompressive hemicraniectomy in malignant MCA strokes leads to improved outcomes, despite the risk of survival with significant disability. Current guidelines support its use in appropriately selected patients.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 99,
    "question": "Case of lateral pontine syndrome (hint was hearing loss)",
    "option_a": "AICA",
    "option_b": "PICA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nLateral pontine syndrome is a brainstem stroke syndrome that results from infarction in the territory of the anterior inferior cerebellar artery (AICA). The involvement of the cochlear nuclei is a key feature that distinguishes this syndrome.\n\n**Pathophysiology**\n\nOcclusion of the AICA leads to ischemia in the lateral aspect of the pons, affecting cranial nerve nuclei (such as the facial nerve) and the cochlear nuclei. This results in deficits including hearing loss, facial paralysis, and sometimes loss of balance due to vestibular involvement.\n\n**Clinical Correlation**\n\nPatients with lateral pontine syndrome typically present with ipsilateral facial weakness, loss of facial sensation, and hearing loss, along with vestibulocochlear disturbances like vertigo. In contrast, lateral medullary (Wallenberg) syndrome, usually from PICA occlusion, does not typically feature hearing loss.\n\n**Diagnostic Approach**\n\nDiagnosis is made based on clinical findings corroborated by imaging studies such as MRI, which can delineate the infarcted territory. Differential diagnoses include lateral medullary syndrome and other brainstem pathologies; the presence of auditory symptoms favors an AICA infarct.\n\n**Management Principles**\n\nManagement is primarily supportive and includes antiplatelet therapy, risk factor modification, and rehabilitation. There is no specific surgical intervention; however, acute stroke protocols (including thrombolysis if within the time window) may be applicable. In pregnancy and lactation, management is conservative with safe antiplatelet regimens and careful monitoring of blood pressure and other risk factors.\n\n**Option Analysis**\n\nOption A (AICA) is correct because the clinical presentation\u2014particularly hearing loss\u2014is characteristic of an AICA infarct. Option B (PICA) is more commonly associated with lateral medullary syndrome, which does not typically present with hearing deficits.\n\n**Clinical Pearls**\n\n1. Hearing loss is a crucial distinguishing feature of lateral pontine syndrome due to AICA involvement. 2. Detailed neurological examination and imaging are essential in differentiating brainstem stroke syndromes.\n\n**Current Evidence**\n\nRecent advances in MRI and MR angiography have improved the accurate localization of brainstem infarcts. Current stroke management guidelines emphasize early diagnosis and supportive care to optimize neurological recovery.",
    "exam_year": "2020",
    "exam_type": "Part I"
  },
  {
    "id": 100,
    "question": "Case scenario of alexia without agraphia, what artery is involved?",
    "option_a": "PCA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAlexia without agraphia (pure alexia) is a disconnection syndrome where a patient loses the ability to read while retaining the ability to write. This occurs due to lesions in the dominant (usually left) occipital lobe and involvement of the splenium of the corpus callosum, which disconnects visual input from language processing areas.\n\n**Pathophysiology**\n\nThe left posterior cerebral artery (PCA) supplies the occipital lobe, including the visual cortex. Infarction in this territory, particularly when it involves the splenium, interrupts the transfer of visual information to the angular gyrus, leading to alexia without agraphia. The neural pathways involved in writing remain intact, preserving the patient\u2019s ability to produce written language.\n\n**Clinical Correlation**\n\nPatients present with the inability to read printed words (alexia), yet they can write normally (without agraphia). This clinical dissociation is a hallmark diagnostic clue for a left PCA stroke affecting the visual cortex and splenium.\n\n**Diagnostic Approach**\n\nDiagnosis is made with neuroimaging, typically MRI with diffusion-weighted imaging, which reveals infarction in the left occipital region and possibly the splenium. Differential diagnoses include other causes of acquired reading disorders, but the combination with a vascular distribution strongly implicates PCA involvement.\n\n**Management Principles**\n\nManagement of PCA strokes includes acute stroke interventions such as IV thrombolysis or mechanical thrombectomy if within the appropriate time window, in addition to secondary prevention measures using antiplatelet agents and risk factor optimization. For pregnant or lactating patients, treatment is adjusted to ensure fetal or neonatal safety, with careful selection of thrombolytic and antiplatelet therapies following current obstetric guidelines.\n\n**Option Analysis**\n\nOption A (PCA) is correct, as the vascular territory of the PCA supplies the areas responsible for visual processing and reading. Lesions in other vascular territories would not produce the specific syndrome of alexia without agraphia.\n\n**Clinical Pearls**\n\n1. The dissociation between preserved writing and impaired reading (alexia without agraphia) is a classic sign of left occipital lobe and splenium involvement. 2. Prompt neuroimaging is critical to identify the infarct and guide appropriate therapeutic interventions.\n\n**Current Evidence**\n\nContemporary stroke management protocols emphasize rapid diagnosis and treatment. Advances in neuroimaging have improved the localization of infarcts, and guidelines continue to support aggressive management of PCA strokes within the thrombolysis and thrombectomy time windows, with adaptations in pregnancy and lactation as needed.",
    "exam_year": "2020",
    "exam_type": "Part I"
  }
]